The Efficacy of Helicobacter pylori Eradication in the Treatment of Idiopathic Thrombocytopenic Purpura – The First Study in Turkey

O. Sayan,A. Akyol Erikçi,A. Ozturk

DOI: https://doi.org/10.1159/000093648

2006-08-01

Acta Haematologica

Abstract:medicine department. The overall median age was 52.5 years (range 16–93). The median age of the 20 patients was 50.8 years (range 21–81). Platelet counts ranged between 14 and 87 ! 10 9 /l (median 38.3 ! 10 9 /l). They received antibiotic therapy for H. pylori eradication (amoxicillin 1,000 mg, clarithromycin 500 mg, and lansaprazole 15 mg twice a day for 14 days). Patients were reevaluated 1 month after the eradication therapy by the urea breath test. The platelet count was monitored monthly in the fi rst year and every 2 months thereafter. Response to treatment was defi ned as partial (PR) if the platelet count was between 100 and 150 ! 10 9 /l and complete (CR) if the platelet count was 1 150 ! 10 9 /l. The others were recorded as non responders (NR). H. pylori eradication was achieved in 18/20 cases (90%). Table 1 shows the main features of the patients and the mean follow-up period with preand posttreatment platelet counts. We achieved normal platelet counts in 8/20 cases (40%) in the fi rst month of eradication therapy (fi g. 1, 2). The median platelet count was 39.7 8 19.2 ! 10 9 /l before and 164.2 8 63.2 ! 10 9 /l after eradication, which was statistically meaningful (p ! 0.05). The mean followup period was 13 months. Five out of 8 patients achieved CR. The median platelet count was 193 ! 10 9 /l and Helicobacter pylori is a gram-negative bacterium that is the main cause of gastritis and peptic ulcer disease [1] . It has been implicated in the pathogenesis of some autoimmune diseases, e.g. Sjogren’s syndrome [2] , and recently, in idiopathic thrombocytopenic purpura (ITP). An immunological response to H. pylori infection has been suggested to play a major role in determining gastro-duodenal damage through the production of cytokines and autoantibodies against gastric epithelial cells [3] . There are data consistent with an association between H. pylori infection and a signifi cant increase in platelet count following H.pylori eradication [4] . The aim of this study was to assess the prevalence of H. pylori infection and the effi cacy of eradication therapy in patients with ITP. Between September 2001 and June 2003 we investigated the presence of gastric H. pylori infection in 34 adult ITP patients (12 females, 22 males) consecutively admitted to our hematology department. ITP was diagnosed on the basis of the presence of isolated thrombocytopenia (platelets ! 100 ! 10 9 /l) and megakaryocytic hyperplasia in bone marrow. Other causes of thrombocytopenia (pseudothrombocytopenia, hepatitis C virus infection, human immunodefi ciency virus infection, drugs, and malignancy) were excluded. Twenty out of the 34 prospectively enrolled ITP patients (59%) had documented H. pylori infection by the urea breath test in our nuclear Received: March 21, 2005 Accepted after revision: November 25, 2005